Halozyme Therapeutics (HALO) Asset Utilization Ratio (2011 - 2026)
Halozyme Therapeutics' (HALO) Asset Utilization Ratio came in at 0.63 for Q2 2026, up 14.3% from 0.55 a year earlier and up 9.2% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
For FY2025, Halozyme Therapeutics' Asset Utilization Ratio stood at 0.61, up 13.8% from FY2024.
- Annual Asset Utilization Ratio has increased for three consecutive years.
- In prior years, Halozyme Therapeutics' Asset Utilization Ratio was 0.53 in FY2024 (+15.3%), 0.46 in FY2023 (+3.5%), 0.45 in FY2022 (-14.9%) and 0.53 in FY2021 (+12.7%).
- The Q2 2026 figure stands as the highest quarterly Asset Utilization Ratio since Q2 2018.
- On a year-over-year basis, Asset Utilization Ratio has increased in each of the last 13 quarters, with growth averaging 14.7% over the last eight quarters.
- The strongest year-over-year quarter for Asset Utilization Ratio in the past five years was Q2 2023, with growth of 33.1%; the weakest was Q3 2022, with a decline of 23.9%.
- According to Business Quant data, Asset Utilization Ratio for the three prior quarters was 0.58 (Q1 2026), 0.59 (Q4 2025) and 0.58 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 0.47 |
| 10 | Halozyme Therapeutics | 12.59 Bn | 11.20 Bn | 401.83 Mn | 0.63 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.63 |
| Mar 31, 2026 | 0.58 |
| Dec 31, 2025 | 0.59 |
| Sep 30, 2025 | 0.58 |
| Jun 30, 2025 | 0.55 |
| Mar 31, 2025 | 0.51 |
| Dec 31, 2024 | 0.49 |
| Sep 30, 2024 | 0.46 |
| Jun 30, 2024 | 0.46 |
| Mar 31, 2024 | 0.48 |
| Dec 31, 2023 | 0.46 |
| Sep 30, 2023 | 0.42 |
| Jun 30, 2023 | 0.44 |
| Mar 31, 2023 | 0.40 |
| Dec 31, 2022 | 0.36 |
| Sep 30, 2022 | 0.32 |
| Jun 30, 2022 | 0.33 |
| Mar 31, 2022 | 0.42 |
| Dec 31, 2021 | 0.39 |
| Sep 30, 2021 | 0.42 |
API Access
Halozyme Therapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();